7WZ9
 
 | | HSA-In agent complex | | 分子名称: | 16-chloranyl-~{N},~{N}-dimethyl-15-thia-1$l^{4},12$l^{4},13-triaza-16$l^{4}-indatetracyclo[8.6.0.0^{2,7}.0^{12,16}]hexadeca-1,3,5,7,9,11,13-heptaen-14-amine, PALMITIC ACID, Serum albumin | | 著者 | Zhang, Z.L, Yang, F. | | 登録日 | 2022-02-17 | | 公開日 | 2023-02-22 | | 最終更新日 | 2023-11-29 | | 実験手法 | X-RAY DIFFRACTION (2.83 Å) | | 主引用文献 | Structure of HSA-In agent complex
To Be Published
|
|
7WOJ
 | | Crystal structure of HSA-Myr complex soaked with cisplatin for one week | | 分子名称: | Albumin, Cisplatin, MYRISTIC ACID | | 著者 | Chen, S.L, Yuan, C, Jiang, L.G, Luo, Z.P, Huang, M.D. | | 登録日 | 2022-01-21 | | 公開日 | 2022-07-20 | | 最終更新日 | 2023-11-29 | | 実験手法 | X-RAY DIFFRACTION (2.89 Å) | | 主引用文献 | Crystallographic analysis of interaction between cisplatin and human serum albumin: Effect of fatty acid.
Int.J.Biol.Macromol., 216, 2022
|
|
7WOK
 | | Crystal structure of HSA soaked with cisplatin for one week | | 分子名称: | Albumin, Cisplatin, PHOSPHATE ION | | 著者 | Chen, S.L, Yuan, C, Jiang, L.G, Luo, Z.P, Huang, M.D. | | 登録日 | 2022-01-21 | | 公開日 | 2022-07-20 | | 最終更新日 | 2023-11-29 | | 実験手法 | X-RAY DIFFRACTION (2.9 Å) | | 主引用文献 | Crystallographic analysis of interaction between cisplatin and human serum albumin: Effect of fatty acid.
Int.J.Biol.Macromol., 216, 2022
|
|
2XVQ
 | |
2I30
 | | Human serum albumin complexed with myristate and salicylic acid | | 分子名称: | 2-HYDROXYBENZOIC ACID, MYRISTIC ACID, Serum albumin | | 著者 | Yang, F, Bian, C, Zhu, L, Zhao, G, Huang, Z, Huang, M. | | 登録日 | 2006-08-17 | | 公開日 | 2006-12-12 | | 最終更新日 | 2023-10-25 | | 実験手法 | X-RAY DIFFRACTION (2.9 Å) | | 主引用文献 | Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin
J.Struct.Biol., 157, 2007
|
|
2BXF
 | | Human serum albumin complexed with diazepam | | 分子名称: | 7-CHLORO-1-METHYL-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE, SERUM ALBUMIN | | 著者 | Ghuman, J, Zunszain, P.A, Petitpas, I, Bhattacharya, A.A, Curry, S. | | 登録日 | 2005-07-26 | | 公開日 | 2005-09-22 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (2.95 Å) | | 主引用文献 | Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.
J.Mol.Biol., 353, 2005
|
|
2BXE
 | | Human serum albumin complexed with diflunisal | | 分子名称: | 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID, SERUM ALBUMIN | | 著者 | Ghuman, J, Zunszain, P.A, Petitpas, I, Bhattacharya, A.A, Curry, S. | | 登録日 | 2005-07-26 | | 公開日 | 2005-09-22 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (2.95 Å) | | 主引用文献 | Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.
J.Mol.Biol., 353, 2005
|
|
6M58
 | |
7WKZ
 | |
6XV0
 | | lauric acid functionalized hexamolybdoaluminate bound to human serum albumin | | 分子名称: | MYRISTIC ACID, Serum albumin, lauric acid functionalized hexamolybdoaluminate | | 著者 | Bijelic, A, Dobrov, A, Roller, A, Rompel, A. | | 登録日 | 2020-01-21 | | 公開日 | 2020-03-18 | | 最終更新日 | 2024-01-24 | | 実験手法 | X-RAY DIFFRACTION (3 Å) | | 主引用文献 | Binding of a Fatty Acid-Functionalized Anderson-Type Polyoxometalate to Human Serum Albumin.
Inorg.Chem., 59, 2020
|
|
5X52
 | |
4N0F
 | |
8ITT
 | |
4HGK
 | | Shark IgNAR variable domain | | 分子名称: | Serum albumin, shark V-NAR antibody | | 著者 | Olland, A.O, Kovalenko, O.V, Svenson, K, King, D. | | 登録日 | 2012-10-08 | | 公開日 | 2013-05-08 | | 最終更新日 | 2023-09-20 | | 実験手法 | X-RAY DIFFRACTION (3.04 Å) | | 主引用文献 | Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis.
J.Biol.Chem., 288, 2013
|
|
2BXD
 | | Human serum albumin complexed with warfarin | | 分子名称: | R-WARFARIN, SERUM ALBUMIN | | 著者 | Ghuman, J, Zunszain, P.A, Petitpas, I, Bhattacharya, A.A, Curry, S. | | 登録日 | 2005-07-26 | | 公開日 | 2005-09-22 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (3.05 Å) | | 主引用文献 | Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.
J.Mol.Biol., 353, 2005
|
|
2VUF
 | |
8EY5
 | | Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 3 | | 分子名称: | COBALT (II) ION, MYRISTIC ACID, Serum albumin | | 著者 | Gucwa, M, Cooper, D.R, Stewart, A.J, Minor, W, Center for Structural Genomics of Infectious Diseases (CSGID), Center for Structural Biology of Infectious Diseases (CSBID) | | 登録日 | 2022-10-26 | | 公開日 | 2022-11-09 | | 最終更新日 | 2024-06-26 | | 実験手法 | X-RAY DIFFRACTION (3.1 Å) | | 主引用文献 | Structural and biochemical characterisation of Co2+-binding sites on serum albumins and their interplay with fatty acids
Chem Sci, 14, 2023
|
|
2BXC
 | | Human serum albumin complexed with phenylbutazone | | 分子名称: | 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE, SERUM ALBUMIN | | 著者 | Ghuman, J, Zunszain, P.A, Petitpas, I, Bhattacharya, A.A, Curry, S. | | 登録日 | 2005-07-26 | | 公開日 | 2005-09-22 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (3.1 Å) | | 主引用文献 | Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.
J.Mol.Biol., 353, 2005
|
|
1BKE
 | | HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID | | 分子名称: | 2,3,5-TRIIODOBENZOIC ACID, MYRISTIC ACID, SERUM ALBUMIN | | 著者 | Curry, S, Mandelkow, H, Brick, P, Franks, N. | | 登録日 | 1998-07-06 | | 公開日 | 1999-01-13 | | 最終更新日 | 2023-08-02 | | 実験手法 | X-RAY DIFFRACTION (3.15 Å) | | 主引用文献 | Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.
Nat.Struct.Biol., 5, 1998
|
|
4S1Y
 | |
2BXB
 | | Human serum albumin complexed with oxyphenbutazone | | 分子名称: | 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE, SERUM ALBUMIN | | 著者 | Ghuman, J, Zunszain, P.A, Petitpas, I, Bhattacharya, A.A, Curry, S. | | 登録日 | 2005-07-26 | | 公開日 | 2005-09-22 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (3.2 Å) | | 主引用文献 | Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.
J.Mol.Biol., 353, 2005
|
|
1O9X
 | | HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN | | 分子名称: | MYRISTIC ACID, PROTOPORPHYRIN IX CONTAINING FE, SERUM ALBUMIN | | 著者 | Zunszain, P.A, Ghuman, J, Komatsu, T, Tsuchida, E, Curry, S. | | 登録日 | 2002-12-20 | | 公開日 | 2003-03-13 | | 最終更新日 | 2023-12-13 | | 実験手法 | X-RAY DIFFRACTION (3.2 Å) | | 主引用文献 | Crystal Structure Analysis of Human Serum Albumin Complexed with Hemin and Fatty Acid
Bmc Struct.Biol., 3, 2003
|
|
5IFO
 | | X-ray structure of HSA-Myr-KP1019 | | 分子名称: | MYRISTIC ACID, RUTHENIUM ION, Serum albumin | | 著者 | Bijelic, A, Theiner, S, Keppler, B.K, Rompel, A. | | 登録日 | 2016-02-26 | | 公開日 | 2016-06-01 | | 最終更新日 | 2024-01-10 | | 実験手法 | X-RAY DIFFRACTION (3.2 Å) | | 主引用文献 | X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.
J.Med.Chem., 59, 2016
|
|
4K2C
 | | HSA Ligand Free | | 分子名称: | Serum albumin | | 著者 | Wang, Y, Luo, Z, Shi, X, Huang, M. | | 登録日 | 2013-04-08 | | 公開日 | 2013-05-01 | | 最終更新日 | 2018-02-21 | | 実験手法 | X-RAY DIFFRACTION (3.23 Å) | | 主引用文献 | Structural mechanism of ring-opening reaction of glucose by human serum albumin.
J. Biol. Chem., 288, 2013
|
|
6ZL1
 | | Crystal structure of human serum albumin in complex with the MCL-1 neutralizing Alphabody CMPX-383B | | 分子名称: | Albumin, CMPX-383B | | 著者 | Pannecoucke, E, Savvides, S.N, Desmet, J, Lasters, I. | | 登録日 | 2020-06-30 | | 公開日 | 2021-04-28 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (3.272 Å) | | 主引用文献 | Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting.
Sci Adv, 7, 2021
|
|
